Huili Wang
Shenyang Pharmaceutical University
4 Papers
Huili Wang is an academic researcher from Shenyang Pharmaceutical University. The author has contributed to research in topics: Photothermal therapy & Cell killing. The author has an hindex of 1, co-authored 3 publications.
Chat about Author
Papers
Gold nanoparticles modified hollow carbon system for dual-responsive release and chemo-photothermal synergistic therapy of tumor.
Qinfu Zhao,Yang Yang,Huili Wang,Wei Lei,Yixuan Liu,Siling Wang +5 more
- 15 Oct 2019
TL;DR: The results of this study indicated that DOX/HMC-Au@PEG has great potential in dual-triggered drug delivery and thermochemotherapy.
54
Red light-emitting carbon dots for reduced phototoxicity and photothermal/photodynamic-enhanced synergistic tumor therapy
TL;DR: In this paper , red-emitting carbon dots (RCDs) with good photothermal conversion ability were synthesized, and photosensitizers Chlorin-e6 (Ce6) were linked onto RCDs to construct the nano-platform RCD-ce6 through amide reaction.
15
Gold nanoparticles gated mesoporous carbon with optimal particle size for photothermal-enhanced thermochemotherapy
TL;DR: In this article, mesoporous carbon nanoparticles (MCNs) have been used in tumor photothermal therapy to achieve the redox-responsive controlled release of anticancer drugs at tumor location, and also realize the photothermalenhanced synergetic thermochemotherapy under a low power irradiation.
14
Evaluation on redox-triggered degradation of thioether-bridged hybrid mesoporous organosilica nanoparticles
TL;DR: In this article, the degradation behavior of colloidal mesoporous silica (CMS) and HCMS nanoparticles in the medium were compared to evaluate the degradability of hybrid organosilica carriers with different contents of doped thioether bonds.